Innovative Medicines Canada has an effective and engaged Board of Directors that enables member companies to achieve common objectives.
Frédéric Fasano, Servier Canada Inc.
John Helou, Pfizer Canada ULC
Jared Rhines, Akcea Therapeutics Canada Inc.
John Haslam, Horizon Therapeutics Canada Inc.
Alok Kanti, Bayer Inc.
Stéphane Lassignardie, AbbVie Corporation
Lisa Matar, Eli Lilly Canada Inc.
Ronnie Miller, Hoffmann-La Roche Limited
Michael Mullette, Sanofi Canada
Sylvie Pilon, Lundbeck Canada Inc.
Al Reba, Bristol-Myers Squibb Canada
Anna van Acker, Merck Canada Inc.